EconPapers    
Economics at your fingertips  
 

Beyond Traditional Cost-Effectiveness Analysis: Operationalizing the Equivalent Income Approach for Equity-Sensitive Health Technology Assessment

Pauline Chauvin () and Clémence Thébaut ()
Additional contact information
Pauline Chauvin: LIRAES (URP_ 4470) - Laboratoire Interdisciplinaire de Recherche Appliquée en Economie de la Santé - UPCité - Université Paris Cité, SUAD_SAFIR - SUAD - Sorbonne University Abu Dhabi, SUAD - Sorbonne University Abu Dhabi
Clémence Thébaut: NET - Neuroépidémiologie Tropicale - CHU Limoges - Institut d'Epidémiologie Neurologique et de Neurologie Tropicale - INSERM - Institut National de la Santé et de la Recherche Médicale - GEIST - Institut Génomique, Environnement, Immunité, Santé, Thérapeutique - UNILIM - Université de Limoges, LEDa - Laboratoire d'Economie de Dauphine - IRD - Institut de Recherche pour le Développement - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres - CNRS - Centre National de la Recherche Scientifique, PSL - Université Paris Sciences et Lettres, UNILIM - Université de Limoges

Post-Print from HAL

Abstract: Background Distributional concerns have gained increasing attention in health technology assessment, complementing traditional cost-effectiveness methods. Among the proposed equity-sensitive frameworks, the equivalent income approach evaluates health interventions by jointly considering health, income, healthcare financing, and societal aversion to inequality. However, its implementation requires additional data and methodological developments. Objective We aimed to provide a practical tutorial for implementing the equivalent income approach in health technology assessment and to compare its recommendations with those derived from conventional cost-effectiveness analysis. Methods We developed a generic individual-level Markov model comparing two hypothetical treatment strategies over a 30-year horizon in a representative sample of the French population. For each individual and cycle, the model estimates health status, income, healthcare costs, willingness-to-pay for health improvements, and health insurance contributions. Individual equivalent incomes are aggregated using a social welfare function incorporating different levels of inequality aversion. In parallel, a conventional cost-effectiveness analysis based on discounted health outcomes and costs was performed. Results Whereas cost-effectiveness analysis recommendations depended solely on treatment effectiveness and costs, the equivalent income approach additionally accounted for the distribution of disease burden, healthcare financing arrangements, and societal preferences regarding inequality. Reimbursement recommendations differed substantially between the two approaches, particularly when disadvantaged populations were disproportionately affected by the disease or exempted from healthcare contributions. Conclusions The equivalent income approach extends conventional cost-effectiveness analysis by explicitly incorporating distributive concerns into health technology assessment. Beyond comparing recommendations, this tutorial provides a transparent and reproducible framework for operationalizing equivalent income-based evaluations and supporting their future use in routine health technology assessment.

Date: 2026-10-23
References: Add references at CitEc
Citations:

Published in PharmacoEconomics, 2026, ⟨10.1007/s40273-026-01676-3⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-05854467

DOI: 10.1007/s40273-026-01676-3

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().

 
Page updated 2026-11-10
Handle: RePEc:hal:journl:hal-05854467